Literature DB >> 29209771

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.

Byron H Lee1, Emily C Zabor2, Daniel Tennenbaum1, Helena Furberg2, Nicole Benfante1, Jonathan A Coleman1, Edgar A Jaimes3, Paul Russo4.   

Abstract

PURPOSE: To understand the longitudinal renal function trends in patients undergoing radical nephroureterectomy (RNU) and identify clinicopathologic characteristics associated with estimated glomerular filtration rate (eGFR) recovery.
METHODS: 147 patients were available for analysis. Longitudinal eGFR trends were assessed by plotting each patient's eGFR measurements over time. The patient population was dichotomized using eGFR < 60 ml/min/1.73 m2 versus ≥ 60 ml/min/1.73 m2. Cumulative incidence and competing risk regression analysis were used to estimate recovery of postoperative eGFR to the preoperative level and identify clinicopathologic characteristics associated with eGFR recovery.
RESULTS: Median age was 68.7 years and median preoperative eGFR was 55.9 ml/min/1.73 m2. 63.6% were male and 95.8% were white. The cumulative incidence of eGFR recovery was significantly higher in patients with baseline eGFR < 60 ml/min/1.73 m2 compared to those with baseline eGFR ≥ 60 ml/min/1.73 m2 (p = 0.01), with recovery rates at 2 years of 56.6% vs. 27.7%, respectively. Multivariable analysis revealed that preoperative hydronephrosis (HR 1.80) and preoperative eGFR < 60 ml/min/1.73 m2 (HR 1.87) were associated with increased chance of eGFR recovery.
CONCLUSION: Over half of patients with preoperative eGFR < 60 ml/min/1.73 m2 achieved eGFR recovery within the first 3 years after RNU, and hydronephrosis was a significant predictor of recovery. These findings should be considered when counseling patients regarding chronic kidney disease progression after RNU and timing of perioperative chemotherapy for high risk tumors.

Entities:  

Keywords:  Hydronephrosis; Radical nephroureterectomy; Renal function recovery; Upper tract urothelial carcinoma

Mesh:

Year:  2017        PMID: 29209771      PMCID: PMC6002847          DOI: 10.1007/s00345-017-2139-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  24 in total

Review 1.  A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.

Authors:  Jeffrey J Leow; William Martin-Doyle; André P Fay; Toni K Choueiri; Steven L Chang; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2014-03-16       Impact factor: 20.096

2.  Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.

Authors:  Thomas Seisen; Ross E Krasnow; Joaquim Bellmunt; Morgan Rouprêt; Jeffrey J Leow; Stuart R Lipsitz; Malte W Vetterlein; Mark A Preston; Nawar Hanna; Adam S Kibel; Maxine Sun; Toni K Choueiri; Quoc-Dien Trinh; Steven L Chang
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

Review 3.  Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.

Authors:  Thomas Seisen; Benoit Peyronnet; Jose Luis Dominguez-Escrig; Harman M Bruins; Cathy Yuhong Yuan; Marko Babjuk; Andreas Böhle; Maximilian Burger; Eva M Compérat; Nigel C Cowan; Eero Kaasinen; Joan Palou; Bas W G van Rhijn; Richard J Sylvester; Richard Zigeuner; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Eur Urol       Date:  2016-07-28       Impact factor: 20.096

4.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

Authors:  Matthew G Kaag; Rebecca L O'Malley; Padraic O'Malley; Guilherme Godoy; Mang Chen; Marc C Smaldone; Ronald L Hrebinko; Jay D Raman; Bernard Bochner; Guido Dalbagni; Michael D Stifelman; Samir S Taneja; William C Huang
Journal:  Eur Urol       Date:  2010-06-25       Impact factor: 20.096

5.  Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.

Authors:  Takeshi Hashimoto; Yoshio Ohno; Jun Nakashima; Tatsuo Gondo; Yoshihiro Nakagami; Kazunori Namiki; Yutaka Horiguchi; Kunihiko Yoshioka; Makoto Ohori; Masaaki Tachibana
Journal:  Jpn J Clin Oncol       Date:  2015-09-09       Impact factor: 3.019

6.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.

Authors:  Brian R Lane; Armine K Smith; Benjamin T Larson; Michael C Gong; Steven C Campbell; Derek Raghavan; Robert Dreicer; Donna E Hansel; Andrew J Stephenson
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

7.  Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma.

Authors:  Nirmish Singla; Bishoy A Gayed; Aditya Bagrodia; Laura-Maria Krabbe; Kerrin L Palazzi; Hossein Mirheydar; Brian Harrow; Corbin Jacobs; Ramy Youssef; Oussama Darwish; Arthur Sagalowsky; Yair Lotan; Ithaar Derweesh; Vitaly Margulis
Journal:  Urol Oncol       Date:  2015-04-07       Impact factor: 3.498

8.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

9.  Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Authors:  Ming-Nan Lai; Shuo-Meng Wang; Pau-Chung Chen; Ya-Yin Chen; Jung-Der Wang
Journal:  J Natl Cancer Inst       Date:  2009-12-21       Impact factor: 13.506

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  5 in total

1.  Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).

Authors:  Alessandro Tafuri; Michele Marchioni; Clara Cerrato; Andrea Mari; Riccardo Tellini; Katia Odorizzi; Alessandro Veccia; Daniele Amparore; Aliasger Shakir; Umberto Carbonara; Andrea Panunzio; Federica Trovato; Michele Catellani; Letizia M I Janello; Lorenzo Bianchi; Giacomo Novara; Fabrizio Dal Moro; Riccardo Schiavina; Elisa De Lorenzis; Paolo Parma; Sebastiano Cimino; Ottavio De Cobelli; Francesco Maiorino; Pierluigi Bove; Fabio Crocerossa; Francesco Cantiello; David D'Andrea; Federica Di Cosmo; Francesco Porpiglia; Pasquale Ditonno; Emanuele Montanari; Francesco Soria; Paolo Gontero; Giovanni Liguori; Carlo Trombetta; Guglielmo Mantica; Marco Borghesi; Carlo Terrone; Francesco Del Giudice; Alessandro Sciarra; Andrea Galosi; Marco Moschini; Shahrokh F Shariat; Marta Di Nicola; Andrea Minervini; Matteo Ferro; Maria Angela Cerruto; Luigi Schips; Vincenzo Pagliarulo; Alessandro Antonelli
Journal:  World J Urol       Date:  2022-10-06       Impact factor: 3.661

2.  Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.

Authors:  Sang Hun Song; Chang Hee Ye; Sangchul Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-09       Impact factor: 4.553

3.  Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma.

Authors:  Jean Hoffman-Censits; Sumanta Pal; Constanze Kaiser; Beiying Ding; Joaquim Bellmunt
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

4.  Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.

Authors:  Rajkumar Chinnadurai; Noel W Clarke; Philip A Kalra
Journal:  BMC Nephrol       Date:  2020-05-29       Impact factor: 2.388

Review 5.  Perioperative complications and adverse sequelae of radical nephroureterectomy.

Authors:  Alison Levy; David Canes
Journal:  Transl Androl Urol       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.